Safe neoadjuvant trastuzumab-based treatment in HER2+inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature

首页> 外文期刊>Journal of international management >Safe neoadjuvant trastuzumab-based treatment in HER2+inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature

【24h】

Safe neoadjuvant trastuzumab-based treatment in HER2+inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature

机译：基于安全的新辅助曲妥珠单抗在葡萄糖6-磷酸脱氢酶缺乏绝经后患者中的葡萄糖6-磷酸性早期乳腺癌治疗方法：案例报告和对文献的审查

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Introduction

机译：介绍

著录项

来源
《Journal of international management》 |2020年第2期|共4页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类管理学;
关键词
Breast cancer; G6PD deficiency; trastuzumab; neoadjuvance;

机译：乳腺癌;G6PD缺乏;Trastuzumab;Neoadjuvant;
入库时间 2022-08-20 09:27:59

相似文献

外文文献
中文文献
专利

1. Safe neoadjuvant trastuzumab-based treatment in HER2+inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature [J] . Journal of international management . 2020,第2期

机译：基于安全的新辅助曲妥珠单抗在葡萄糖6-磷酸脱氢酶缺乏绝经后患者中的葡萄糖6-磷酸性早期乳腺癌治疗方法：案例报告和对文献的审查
2. Safe chemotherapy and hormone therapy for treating early breast cancer in a glucose 6-phosphate dehydrogenase-deficient patient: Case report [J] . LaVerdeN., BramatiA., GirelliS., Anti-cancer drugs . 2012,第7期

机译：安全的化学疗法和激素疗法可治疗6磷酸葡萄糖脱氢酶缺乏症的早期乳腺癌：病例报告
3. Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines [J] . Lauren I. Madigan, Phuong Dinh, J. Dinny Graham Breast Cancer Research . 2020,第1期

机译：Neoadjuvant内分泌治疗在局部晚期雌激素或黄体酮受体阳性乳腺癌：确定绝经后妇女的最佳内分泌剂和治疗持续时间 - 是文献审查和拟议指导方针
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. Evaluating the safety of malaria treatment in glucose-6-phosphate dehydrogenase-deficient individuals: evidence and tools to support malaria elimination. [D] . Poirot, Eugenie Aude Marguerite. 2016

机译：评估6-磷酸葡萄糖磷酸脱氢酶缺乏症患者疟疾治疗的安全性：支持消除疟疾的证据和工具。
6. Unilateral Orbital Metastasis as the Unique Symptom in the Onset of Breast Cancer in a Postmenopausal Woman: Case Report and Review of the Literature [O] . Cristina Marinela Oprean, Larisa Maria Badau, Nusa Alina Segarceanu, 2021

机译：单侧轨道转移作为绝经后妇女乳腺癌发病中的独特症状：案例报告和文献审查
7. Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines [O] . Lauren I. Madigan, Phuong Dinh, J. Dinny Graham 2020

机译：Neoadjuvant内分泌治疗在局部晚期雌激素或黄体酮受体阳性乳腺癌：确定绝经后妇女的最佳内分泌剂和治疗持续时间 - 是文献审查和拟议指导方针

Safe neoadjuvant trastuzumab-based treatment in HER2+inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature

摘要

著录项

相似文献

相关主题

期刊订阅